BLACKROCK TECH & PRIV EQTY (BTX) Fundamental Analysis & Valuation

NYSE:BTX • US09260Q1085

6.42 USD
-0.11 (-1.68%)
At close: Mar 6, 2026
6.45 USD
+0.03 (+0.47%)
After Hours: 3/6/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis News

This BTX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

Overall BTX gets a fundamental rating of 2 out of 10. We evaluated BTX against 0 industry peers in the Unkown industry. BTX has a bad profitability rating. Also its financial health evaluation is rather negative. BTX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. BTX Profitability Analysis

1.1 Basic Checks

  • In the past year BTX was profitable.
  • BTX had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: BTX reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: BTX reported negative operating cash flow in multiple years.
BTX Yearly Net Income VS EBIT VS OCF VS FCFBTX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B -4B

1.2 Ratios

Industry RankSector Rank
ROA 2.2%
ROE 2.23%
ROIC N/A
ROA(3y)-22.76%
ROA(5y)-40.42%
ROE(3y)-23.08%
ROE(5y)-120.83%
ROIC(3y)N/A
ROIC(5y)N/A
BTX Yearly ROA, ROE, ROICBTX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400 -500

1.3 Margins

  • The Operating Margin and Gross Margin are not available for BTX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 655.74%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BTX Yearly Profit, Operating, Gross MarginsBTX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K -40K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. BTX Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, BTX has less shares outstanding
  • The number of shares outstanding for BTX has been increased compared to 5 years ago.
  • BTX has a better debt/assets ratio than last year.
BTX Yearly Shares OutstandingBTX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
BTX Yearly Total Debt VS Total AssetsBTX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • An Altman-Z score of 26.92 indicates that BTX is not in any danger for bankruptcy at the moment.
  • The Debt to FCF ratio of BTX is 0.04, which is an excellent value as it means it would take BTX, only 0.04 years of fcf income to pay off all of its debts.
  • A Debt/Equity ratio of 0.01 indicates that BTX is not too dependend on debt financing.
  • Although BTX's pure debt/equity ratio does not look good, it has limited outstanding debt compared to the Free Cash Flow. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.04
Altman-Z 26.92
ROIC/WACCN/A
WACCN/A
BTX Yearly LT Debt VS Equity VS FCFBTX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

2.3 Liquidity

  • A Current Ratio of 0.57 indicates that BTX may have some problems paying its short term obligations.
  • A Quick Ratio of 0.57 indicates that BTX may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.57
Quick Ratio 0.57
BTX Yearly Current Assets VS Current LiabilitesBTX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. BTX Growth Analysis

3.1 Past

  • The earnings per share for BTX have decreased strongly by -81.91% in the last year.
  • The Revenue has grown by 23.65% in the past year. This is a very strong growth!
  • Measured over the past years, BTX shows a very negative growth in Revenue. The Revenue has been decreasing by -22.63% on average per year.
EPS 1Y (TTM)-81.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.23%
Revenue 1Y (TTM)23.65%
Revenue growth 3Y-14.65%
Revenue growth 5Y-22.63%
Sales Q2Q%54.77%

3.2 Future

  • Based on estimates for the next years, BTX will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.02% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y22.47%
EPS Next 2Y18.02%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BTX Yearly Revenue VS EstimatesBTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
BTX Yearly EPS VS EstimatesBTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -20 -40 -60

More info and screens

Find the best growth stocksShow best growing peers

1

4. BTX Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 37.76, the valuation of BTX can be described as expensive.
  • BTX is valuated rather expensively when we compare the Price/Earnings ratio to 26.29, which is the current average of the S&P500 Index.
  • BTX is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 37.76
Fwd PE N/A
BTX Price Earnings VS Forward Price EarningsBTX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF 4.33
EV/EBITDA N/A
BTX Per share dataBTX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 -6

4.3 Compensation for Growth

  • BTX's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as BTX's earnings are expected to grow with 18.02% in the coming years.
PEG (NY)1.68
PEG (5Y)N/A
EPS Next 2Y18.02%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BTX Dividend Analysis

5.1 Amount

  • BTX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BTX Fundamentals: All Metrics, Ratios and Statistics

BLACKROCK TECH & PRIV EQTY

NYSE:BTX (3/6/2026, 8:04:00 PM)

After market: 6.45 +0.03 (+0.47%)

6.42

-0.11 (-1.68%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-11
Earnings (Next)11-17
Inst Owners12.89%
Inst Owner Change0%
Ins Owners0.02%
Ins Owner Change0%
Market Cap0
Revenue(TTM)5.49M
Net Income(TTM)36.00M
Analysts80
Price TargetN/A
Short Float %0.02%
Short Ratio0.06
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP622.22%
Div Incr Years1
Div Non Decr Years1
Ex-Date06-15
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 37.76
Fwd PE N/A
P/S 249.08
P/FCF 4.33
P/OCF 4.33
P/B 0.85
P/tB 0.85
EV/EBITDA N/A
EPS(TTM)0.17
EY2.65%
EPS(NY)-6.25
Fwd EYN/A
FCF(TTM)1.48
FCFY23.11%
OCF(TTM)1.48
OCFY23.11%
SpS0.03
BVpS7.56
TBVpS7.56
PEG (NY)1.68
PEG (5Y)N/A
Graham Number5.38
Profitability
Industry RankSector Rank
ROA 2.2%
ROE 2.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 655.74%
GM N/A
FCFM 5755.92%
ROA(3y)-22.76%
ROA(5y)-40.42%
ROE(3y)-23.08%
ROE(5y)-120.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.04
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 877.78%
Current Ratio 0.57
Quick Ratio 0.57
Altman-Z 26.92
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-81.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.23%
EPS Next Y22.47%
EPS Next 2Y18.02%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23.65%
Revenue growth 3Y-14.65%
Revenue growth 5Y-22.63%
Sales Q2Q%54.77%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y20.86%
FCF growth 3YN/A
FCF growth 5Y178.61%
OCF growth 1Y20.86%
OCF growth 3YN/A
OCF growth 5Y151.66%

BLACKROCK TECH & PRIV EQTY / BTX FAQ

What is the ChartMill fundamental rating of BLACKROCK TECH & PRIV EQTY (BTX) stock?

ChartMill assigns a fundamental rating of 2 / 10 to BTX.


Can you provide the valuation status for BLACKROCK TECH & PRIV EQTY?

ChartMill assigns a valuation rating of 1 / 10 to BLACKROCK TECH & PRIV EQTY (BTX). This can be considered as Overvalued.


What is the profitability of BTX stock?

BLACKROCK TECH & PRIV EQTY (BTX) has a profitability rating of 1 / 10.


What are the PE and PB ratios of BLACKROCK TECH & PRIV EQTY (BTX) stock?

The Price/Earnings (PE) ratio for BLACKROCK TECH & PRIV EQTY (BTX) is 37.76 and the Price/Book (PB) ratio is 0.85.


What is the expected EPS growth for BLACKROCK TECH & PRIV EQTY (BTX) stock?

The Earnings per Share (EPS) of BLACKROCK TECH & PRIV EQTY (BTX) is expected to grow by 22.47% in the next year.